Zhejiang Hisun Pharmaceutical Co., Ltd. provided earnings guidance for 2012. According to preliminary statistics of its financial department, the company predicts a year-on-year decrease of between 35% and 45% in the net profit owned by shareholders of the listed company in 2012.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.58 CNY | -1.94% | -3.93% | -19.02% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.02% | 1.26B | |
+42.54% | 739B | |
+32.34% | 598B | |
-6.05% | 353B | |
+17.37% | 318B | |
+3.34% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.62% | 164B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd. Provides Earnings Guidance for 2012